Bristol-Myers Squibb ($BMY) took a top-line hit in 2014, but that's mostly because it sold its share of a diabetes alliance to partner AstraZeneca ($AZN). This year ...
This notice was approved by the Ontario Superior Court of Justice and the Superior Court of Québec. Please read it carefully as it may affect your legal rights. TORONTO and MONTREAL, March 17, 2025 ...
May 28 (Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.
Makers of the blockbuster drug Abilify have until September 1 to come up with a way to settle more than 800 lawsuits that claim the anti-psychotic and anti-depressive drug spurred uncontrollable urges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback